ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

OSE OSE Immunotherapeutics

6,20
-0,04 (-0,64%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
OSE Immunotherapeutics OSE Euronext Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,04 -0,64% 6,20 12:40:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,24 6,08 6,48 6,20 6,24
mais cotações »

Notícias Recentes

Data Hora Fonte Título
02/05/202413:00GLOBEMise à disposition du Document d’Enregistrement Universel ..
16/04/202413:00GLOBEOSE Immunotherapeutics’ Global License to Develop a Novel..
10/04/202413:00GLOBEOSE Immunotherapeutics reçoit un financement public de 8,4..
03/04/202413:00GLOBEInformations relatives au nombre total de droits de vote et..
02/04/202402:30GLOBEOSE Immunotherapeutics Announces Peer-Reviewed Publication..
27/03/202414:00GLOBEOSE Immunotherapeutics publie ses résultats financiers..
18/03/202403:30BWOSE Immunotherapeutics annonce la fin du recrutement dans..
01/03/202414:00BWOSE Immunotherapeutics : Informations relatives au nombre..
28/02/202403:45BWOSE Immunotherapeutics to Host a Live Webcast to Discuss..
28/02/202403:30BWAbbVie et OSE Immunotherapeutics annoncent un partenariat..
26/02/202414:00BWOSE Immunotherapeutics Provides Update on Clinical Results..
02/02/202414:00BWOSE Immunotherapeutics : Informations relatives au nombre..
19/01/202403:30BWOSE Immunotherapeutics Highlights Clinical Portfolio..
05/01/202414:00BWOSE Immunotherapeutics : Informations relatives au nombre..
11/12/202303:30BWOSE Immunotherapeutics and Nantes University Hospital..
05/12/202314:00BWOSE Immunotherapeutics : Informations relatives au nombre..
21/11/202314:00BWOSE Immunotherapeutics Announces a Collaboration Agreement..
06/11/202314:00BWOSE Immunotherapeutics : Informations relatives au nombre..
23/10/202313:00BWOSE Immunotherapeutics Announces First Clinical Results for..
16/10/202302:30BWOSE Immunotherapeutics Presents First Positive Clinical..
05/10/202313:00BWOSE Immunotherapeutics : Informations relatives au nombre..
27/09/202313:03BWOSE Immunotherapeutics Announces H1 2023 Results and..
20/09/202302:30BWOSE Immunotherapeutics Updates on its Research Programs in..
11/09/202313:00BWOSE Immunotherapeutics Announces: Positive Phase 3 Data from..
04/09/202313:00BWOSE Immunotherapeutics : Informations relatives au nombre..
01/08/202302:30BWOSE Immunotherapeutics annonce une nouvelle aide publique..
19/07/202313:00BWOSE Immunotherapeutics annonce une publication sur OSE-230,..
11/07/202313:00BWOSE Immunotherapeutics and Nantes University Hospital..
10/07/202313:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/07/202302:30BWOSE Immunotherapeutics Announces for Lusvertikimab, its..
04/07/202313:00BWOSE Immunotherapeutics Announces New US Patent Granted for..
22/06/202313:00BWOSE Immunotherapeutics : Résultats de l’Assemblée générale..
20/06/202313:00BWOSE Immunotherapeutics Receives €1.5 M in Funding from..
15/06/202302:30BWOSE Immunotherapeutics présente les dernières données sur..
12/06/202313:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/06/202302:30BWOSE Immunotherapeutics présente des abstracts cliniques sur..
01/06/202313:00BWOSE Immunotherapeutics SA : Mise à disposition des documents..
31/05/202313:00BWLe Conseil d’administration d’OSE Immunotherapeutics propose..
12/05/202313:15BWOSE Immunotherapeutics : Informations relatives au nombre..
12/05/202313:00BWOSE Immunotherapeutics to Continue the Clinical Development..

Seu Histórico Recente

Delayed Upgrade Clock